Analytical Data
-
Gene name
FAM181A
- Application
-
Alternative Names
FAM181A; C14orf152; HSD-31; HSD31Protein FAM181A
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N9Y4
-
Expression Region
1-354aa
-
AA Sequence
MPLEERRSSG ERNDAAPTNH RRPGEKRAST AKQVSSVPFL GAAGHQQSLP SSWKASCSGP LVMASDSDVK MLLNFVNLAS SDIKAALDKS APCRRSVDHR KYLQKQLKRF SQKYSRLPRG LPGRAAEPYL KRGSEDRPRR LLLDLGPDSS PGGGGGCKEK VLRNPYREEC LAKEQLPQRQ HPEAAQPGQV PMRKRQLPAS FWEEPRPTHS YHVGLEGGLG PREGPPYEGK KNCKGLEPLG PETTLVSMSP RALAEKEPLK MPGVSLVGRV NAWSCCPFQY HGQPIYPGPL GALPQSPVPS LGLWRKSPAF PGELAHLCKD VDGLGQKVCR PVVLKPIPTK PAVPPPIFNV FGYL
-
Molecular Weight
38.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM181A, a member of the FAM family of proteins, has emerged as a significant subject of research due to its potential roles in various biological processes and disease mechanisms. Originally characterized through genome-wide association studies, FAM181A has been implicated in several conditions, including cancer and autoimmune diseases, suggesting that it may play a crucial role in cellular signaling pathways and immune responses. Recent studies have highlighted the protein's involvement in regulating cellular functions such as proliferation, differentiation, and apoptosis, indicating its relevance in both normal physiology and pathological conditions. The development of recombinant FAM181A protein has facilitated the exploration of its structure-function relationships and interactions with other cellular molecules, paving the way for potential therapeutic applications. Understanding the precise biological roles and mechanisms of action of FAM181A is not only essential for elucidating its contribution to disease processes but also for identifying it as a potential biomarker or therapeutic target. As research continues to advance, FAM181A is gaining recognition for its importance in molecular biology and drug development, emphasizing the need for further investigation into its functional capabilities and therapeutic implications.
